Jane Street’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.4M | Sell |
760,122
-304,051
| -29% | -$11M | 0.01% | 375 |
|
|
2025
Q1 | $33.1M | Buy |
1,064,173
+779,246
| +273% | +$24.3M | 0.01% | 290 |
|
|
2024
Q4 | $7.27M | Buy |
284,927
+79,121
| +38% | +$2.02M | ﹤0.01% | 908 |
|
|
2024
Q3 | $5.82M | Sell |
205,806
-77,611
| -27% | -$2.2M | ﹤0.01% | 1173 |
|
|
2024
Q2 | $7.47M | Buy |
283,417
+193,416
| +215% | +$5.1M | ﹤0.01% | 1292 |
|
|
2024
Q1 | $2.73M | Sell |
90,001
-327,258
| -78% | -$9.94M | ﹤0.01% | 1916 |
|
|
2023
Q4 | $11.7M | Buy |
417,259
+342,561
| +459% | +$9.62M | ﹤0.01% | 833 |
|
|
2023
Q3 | $2.03M | Sell |
74,698
-53,439
| -42% | -$1.45M | ﹤0.01% | 2224 |
|
|
2023
Q2 | $3.94M | Buy |
128,137
+90,804
| +243% | +$2.79M | ﹤0.01% | 1712 |
|
|
2023
Q1 | $1.35M | Buy |
37,333
+9,517
| +34% | +$343K | ﹤0.01% | 2467 |
|
|
2022
Q4 | $1.1M | Buy |
27,816
+9,166
| +49% | +$362K | ﹤0.01% | 2568 |
|
|
2022
Q3 | $749K | Buy |
18,650
+12,860
| +222% | +$516K | ﹤0.01% | 3126 |
|
|
2022
Q2 | $243K | Sell |
5,790
-582
| -9% | -$24.4K | ﹤0.01% | 4287 |
|
|
2022
Q1 | $248K | Sell |
6,372
-27,987
| -81% | -$1.09M | ﹤0.01% | 4492 |
|
|
2021
Q4 | $1.37M | Sell |
34,359
-6,206
| -15% | -$247K | ﹤0.01% | 2367 |
|
|
2021
Q3 | $1.47M | Sell |
40,565
-32,142
| -44% | -$1.16M | ﹤0.01% | 2205 |
|
|
2021
Q2 | $2.98M | Buy |
72,707
+53,870
| +286% | +$2.21M | ﹤0.01% | 1362 |
|
|
2021
Q1 | $822K | Buy |
18,837
+12,646
| +204% | +$552K | ﹤0.01% | 2742 |
|
|
2020
Q4 | $310K | Buy |
+6,191
| New | +$310K | ﹤0.01% | 3113 |
|
|
2020
Q3 | – | Sell |
-42,425
| Closed | -$2.06M | – | 4333 |
|
|
2020
Q2 | $2.06M | Buy |
+42,425
| New | +$2.06M | ﹤0.01% | 1323 |
|